These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33896060)

  • 1. The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid.
    Ständer S; Hammers CM; Vorobyev A; Schmidt E; Zillikens D; Ghorbanalipoor S; Bieber K; Ludwig RJ; Kridin K
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):1702-1711. PubMed ID: 33896060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with bullous pemphigoid and comorbid psoriasis present with less blisters and lower serum levels of anti-BP180 autoantibodies.
    Ständer S; Schmidt E; Zillikens D; Thaçi D; Ludwig RJ; Kridin K
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):981-987. PubMed ID: 33098720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti-BP230 seropositivity.
    Ständer S; Hammers CM; Vorobyev A; Schmidt E; Hundt JE; Sadik CD; Lange T; Zillikens D; Ludwig RJ; Kridin K
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2067-2073. PubMed ID: 33896070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.
    Nakama K; Koga H; Ishii N; Ohata C; Hashimoto T; Nakama T
    JAMA Dermatol; 2018 Mar; 154(3):347-350. PubMed ID: 29299596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
    Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
    Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid-Insights from a Retrospective Cohort Study.
    Ständer S; Holtsche MM; Schmidt E; Hammers CM; Zillikens D; Ludwig RJ; Kridin K
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33287364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
    Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
    Front Immunol; 2019; 10():1934. PubMed ID: 31474998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization.
    García-Díez I; Ivars-Lleó M; López-Aventín D; Ishii N; Hashimoto T; Iranzo P; Pujol RM; España A; Herrero-Gonzalez JE
    Int J Dermatol; 2018 Jul; 57(7):810-816. PubMed ID: 29682739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
    Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
    Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
    J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-predominant lesional inflammatory infiltrates of the skin are associated with mucosal-dominant phenotype in pemphigus.
    Papara C; Danescu S; Rogojan L; Leucuta DC; Candrea E; Zillikens D; Baican A
    J Cutan Pathol; 2023 Aug; 50(8):754-762. PubMed ID: 36680509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
    Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
    Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
    Hashimoto T; Ohzono A; Teye K; Numata S; Hiroyasu S; Tsuruta D; Hachiya T; Kuroda K; Hashiguchi M; Kawakami T; Ishii N
    Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
    Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
    J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.